LYEL vs XOM · rev $6.0K vs P/E 24, rev $201.16B
Lyell Immunopharma Inc (LYEL) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Lyell Immunopharma Inc (LYEL) is a biotechnology company listed on US.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE. It is led by Darren W. Woods.
Latest reported LYEL revenue for 2026-06-30 was $6.0K. Net income was -$68.9M. LYEL currently screens at market cap $143.5M.
Latest reported XOM revenue for 2026-06-30 was $201.16B. Net income was $18.71B. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
LYEL currently screens at market cap $143.5M. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the LYEL and XOM stock pages for the full models.
Not investment advice.